Demographics and clinical characteristics of the participants
| Variable | Non-MI (n=100) | MI (n=100) | P value* |
| Age (years) | 59.6 (±8.8) | 59.4 (±8.8) | – |
| Sex (male/female), n | 76/24 | 76/24 | – |
| Smoking at admission, n | |||
| Current smoker | 11 | 31 | 0.002 |
| Ex-smoker | 44 | 33 | |
| Smoking at follow-up, n | |||
| Current smoker | 11 | 14 | 0.301 |
| Ex-smoker | 44 | 51 | |
| Peripheral artery disease (n) | 0 | 2 | 0.497 |
| Diabetes (n) | 14 | 21 | 0.366 |
| Rheumatic disease (n) | 16 | 14 | 0.692 |
| Pulmonary disease (n) | 5 | 16 | 0.012 |
| Kidney disease (n) | 3 | 3 | – |
| WC (cm) | 97.2 (±13.2) | 99.3 (±12.5) | 0.241 |
| BMI (kg/m2) | 26.7 (±4.7) | 27.4 (±4.3) | 0.286 |
| SBP (mm Hg) | 136.0 (±17.9) | 130.7 (±17.2) | 0.033 |
| DBP (mm Hg) | 83.6 (±11.4) | 77.2 (±10.2) | <0.001 |
| Pharmacological treatment at follow-up, n | |||
| Renin–angiotensin inhibitors | 13 | 73 | <0.001 |
| Aspirin | 10 | 98 | <0.001 |
| β-blockers | 11 | 91 | <0.001 |
| Statins | 12 | 97 | <0.001 |
| Anti-inflammatory agents | 3 | 1 | 0.621 |
| Corticosteroids | 5 | 1 | 0.212 |
| Laboratory | |||
| HbA1c (mmol/mol) | 39.0 (±6.4) | 40.7 (±8.4) | 0.119 |
| Triglycerides (mmol/L) | 1.5 (±2.1) | 1.3 (±0.7) | 0.296 |
| Total cholesterol (mmol/L) | 5.4 (±1.1) | 4.0 (±0.7) | <0.001 |
| HDL cholesterol (mmol/L) | 1.5 (±0.4) | 1.3 (±0.4) | 0.001 |
| Fibrinogen (g/L) | 3.0 (±0.7) | 3.4 (±0.8) | 0.001 |
| Apolipoprotein B (g/L) | 2.3 (±12.2) | 0.8 (±0.2) | 0.276 |
| Apolipoprotein A1 (g/L) | 3.5 (±17.8) | 1.4 (±0.3) | 0.319 |
| hs-CRP (mg/L) | 2.2 (±2.8) | 2.4 (±2.5) | 0.596 |
| WCC (×109/L) | 5.5 (±1.4) | 6.5 (±1.7) | <0.001 |
| Periodontal parameters | |||
| No of teeth | 24.3 (±5.5) | 21.1 (±7.9) | 0.001 |
| PPD≥4 mm (%) | 11.1 (±12.6) | 24.6 (±48.4) | <0.001 |
| Bone loss (%) | 18.1 (±8.4) | 25.9 (±23.5) | <0.001 |
Continuous variables are presented as mean and SD and categorical variables as natural frequencies.
*P values were compared by t-test or χ2/Fisher’s exact test.
BMI, body mass index; DBP, diastolic blood pressure; HbA1c, glycohaemoglobin A1c; HDL, high-density lipoproteins; hs-CRP, high-sensitivity C reactive protein; MI, myocardial infarction; PPD, probing pocket depth; SBP, systolic blood pressure; WC, waist circumference; WCC, white cell count.